Wealth Enhancement Advisory Services
ALXO icon

Wealth Enhancement Advisory Services’s ALX Oncology ALXO Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.8K Buy
38,011
+14
+0% +$25 ﹤0.01% 3841
2026
Q1 		$74.9K Buy
37,997
+5
+0% +$10 ﹤0.01% 3370
2025
Q4 		$41K Sell
37,992
-81
-0.2% -$123 ﹤0.01% 3540
2025
Q3 		$69.7K Sell
38,073
-1,206
-3% -$1.04K ﹤0.01% 3386
2025
Q2 		$18.1K Sell
39,279
-1,272
-3% -$642 ﹤0.01% 3311
2025
Q1 		$25.3K Buy
40,551
+1,420
+4% +$1.71K ﹤0.01% 2902
2024
Q4 		$65.3K Buy
39,131
+7,421
+23% +$11.4K ﹤0.01% 2844
2024
Q3 		$57.7K Buy
31,710
+291
+0.9% +$1.08K ﹤0.01% 2609
2024
Q2 		$189K Buy
+31,419
New +$386K ﹤0.01% 2311

Other funds holding ALXO

New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
JF
JSF Financial Los Angeles, California $632M AUM 27.63% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Wealth Enhancement Advisory Services's ALXO Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its ALX Oncology (ALXO) stake by 0.04% in Q2 2026, buying an estimated $25 and bringing the position to 38,011 shares worth $80.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3841.

Wealth Enhancement Advisory Services first reported a position in ALXO in Q2 2024 and has held it in 9 quarters since. The position peaked at $189K in Q2 2024. 10 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

  • Wealth Enhancement Advisory Services held 38,011 shares of ALX Oncology worth $80.8K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 14 ALX Oncology shares in Q2 2026, an estimated $25.
  • ALX Oncology made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3841 holding.
  • Wealth Enhancement Advisory Services first reported a position in ALX Oncology in Q2 2024 and has held it in 9 quarters since.
  • Wealth Enhancement Advisory Services's ALX Oncology position peaked at $189K in Q2 2024.
  • 10 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.